Algert Global LLC Aeglea Bio Therapeutics, Inc. Transaction History

Algert Global LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.5 - $2.66 $28,472 - $151,471	-56,944 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.87 - $4.77 $45,852 - $116,960	24,520 Added 75.62%	56,944 $131,000
Q4 2021 Feb 14, 2022	SELL	$3.5 - $8.42 $15,330 - $36,879	-4,380 Reduced 11.9%	32,424 $154,000
Q3 2021 Nov 15, 2021	SELL	$6.03 - $7.95 $28,316 - $37,333	-4,696 Reduced 11.32%	36,804 $293,000
Q2 2021 Aug 13, 2021	SELL	$6.32 - $8.38 $160,022 - $212,181	-25,320 Reduced 37.89%	41,500 $289,000
Q1 2021 May 14, 2021	SELL	$6.76 - $8.57 $249,308 - $316,061	-36,880 Reduced 35.56%	66,820 $529,000
Q4 2020 Feb 12, 2021	SELL	$7.02 - $9.83 $30,536 - $42,760	-4,350 Reduced 4.03%	103,700 $816,000
Q3 2020 Nov 16, 2020	BUY	$6.51 - $9.33 $703,405 - $1.01 Million	108,050 New	108,050 $766,000
Q4 2019 Feb 18, 2020	SELL	$7.23 - $8.55 $169,109 - $199,984	-23,390 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$6.42 - $9.0 $8,538 - $11,970	1,330 Added 6.03%	23,390 $180,000
Q2 2019 Aug 14, 2019	BUY	$6.1 - $8.78 $22,673 - $32,635	3,717 Added 20.26%	22,060 $151,000
Q1 2019 May 01, 2019	SELL	$7.6 - $9.4 $55,730 - $68,930	-7,333 Reduced 28.56%	18,343 $148,000
Q4 2018 Feb 01, 2019	BUY	$6.51 - $10.19 $167,150 - $261,638	25,676 New	25,676 $192,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.